Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5113243 | 0.83 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL30538012 | 0.82 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5122847 | 0.82 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5121597 | 0.79 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5106741 | 0.78 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5110990 | 0.77 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5121705 | 0.77 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5120386 | 0.77 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5113187 | 0.76 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 | |
| SCHEMBL5114061 | 0.76 | PTGDR2 (1.00) | PTGDR2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1784182-A1 | 2-SULFANYL-BENZIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006021418-A1 | 2-SULFANYL-BENZOIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-03-02 | — | — | WO | disclosed |